Brief: Bone Therapeutics End-H1 Cash And Cash Equivalents Of EUR 9.10 Million

Biosenic SA

30/08/2018 06:21

Aug 30 (Reuters) - BONE THERAPEUTICS SA  BOTHE.BR :
    * REG-BONE THERAPEUTICS SA ANNOUNCES H1 RESULTS FOR 2018
    * DURING FIRST SIX MONTHS OF 2018, TOTAL OPERATING INCOME
AMOUNTED
TO EUR 1.88 MILLION
    * H1 OPERATING LOSS FOR PERIOD AMOUNTED TO EUR 6.08 MILLION,
COMPARED TO EUR 6.16 MILLION IN H1 2017
    * COMPANY ENDED FIRST SIX MONTHS OF 2018 WITH EUR 9.10
MILLION IN
CASH AND CASH EQUIVALENTS
    * CONFIRMS EXPECTED CASH BURN (EXCLUDING PROCEEDS FROM
FINANCING)
FOR FULL YEAR 2018 TO BE IN RANGE OF EUR 15-16 MILLION IN LINE
WITH PREVIOUS GUIDANCE
    * COMPANY EXPECTS TO HAVE SUFFICIENT CASH TO CARRY OUT ITS
OBJECTIVES UNTIL END OF Q3 2019

Source text for Eikon:  ID:nGNE5vtWRS 
Further company coverage:  BOTHE.BR 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))